Kite Lake Capital Management (UK) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
+$24M |
| 2 |
Qiagen
QGEN
|
+$6.33M |
| 3 |
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
|
+$1.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$78.8M |
| 2 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$34.9M |
| 3 |
VSM
Versum Materials, Inc.
VSM
|
+$26.8M |
| 4 |
Pacific Biosciences
PACB
|
+$19M |
| 5 |
PVTL
Pivotal Software, Inc.
PVTL
|
+$14.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.32% |
| 2 | Consumer Discretionary | 0% |
| 3 | Industrials | 0% |
| 4 | Materials | 0% |
| 5 | Technology | 0% |
Similar funds
Kite Lake Capital Management (UK)'s Q4 2019 Portfolio in Review
As of Q4 2019, Kite Lake Capital Management (UK) held 9 positions worth $31.6M, down 83% from $188M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Kite Lake Capital Management (UK) withdrew a net $157M in Q4 2019, closing 6 positions. Its most notable exit was WABCO HOLDINGS INC., an estimated $78.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Kite Lake Capital Management (UK) opened a new position in China Biologic Products Holdings, Inc. worth $24.1M.
- Kite Lake Capital Management (UK)'s largest Q4 2019 buy was China Biologic Products Holdings, Inc.: 207,382 shares worth $24.1M.
- Kite Lake Capital Management (UK) fully exited WABCO HOLDINGS INC. in Q4 2019, selling an estimated $78.8M.
- Kite Lake Capital Management (UK)'s ten largest holdings make up 100% of its $31.6M portfolio in Q4 2019.
- Kite Lake Capital Management (UK) opened 3 new positions and closed 6 in Q4 2019.
- Kite Lake Capital Management (UK)'s portfolio value fell 83% quarter-over-quarter to $31.6M.
Based on Kite Lake Capital Management (UK)'s 13F filing for Q4 2019, filed 14 Feb 2020.